Human Plasma Distribution of Free Paclitaxel and Paclitaxel Associated with Diblock Copolymers
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Amphiphilic diblock copolymer poly (D,L-lactide)-block-methoxy polyethylene glycol was synthesized, and paclitaxel (Taxol) was incorporated into this copolymer above its critical micelle concentration (cmc), resulting in the formation of polymeric micellar paclitaxel (PMT). Free paclitaxel dissolved in acetonitrile (TAX) and PMT, at 10 micrograms of paclitaxel/mL of human plasma, were incubated for 5, 30, and 60 min at 37 degrees C. Following incubation, the plasma was separated into its high-density (HDL), low-density (LDL), very-low-density (VLDL) lipoprotein and lipoprotein-deficient (LPDP) plasma fractions by density gradient ultracentrifugation. Each of these lipoprotein (LP) and LPDP fractions were analyzed for paclitaxel and plasma lipid levels by well-established HPLC and enzymatic assays. When TAX was incubated in human plasma for 5 min, an equal amount of drug was found in the LP and LPDP fractions. This distribution profile did not change following incubation for 30 and 60 min. Of the amount of TAX that was distributed within the LP fraction, 70-75% of TAX was associated with the HDL fraction for all time points studied. The paclitaxel plasma and LP distribution profile for PMT was similar to the distribution profile of TAX, suggesting that the plasma and LP distribution of paclitaxel is independent of the method of paclitaxel delivery and that LP distribution is not a function of mass lipid levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhu, K. J., Xiangzhou, L., & Shilin, Y. (1990) · Journal of Applied Polymer Science · doi:10.1002/app.1990.070390101 · Cited by 313
Cited by
Micellar Nanocarriers: Pharmaceutical Perspectives
Torchilin, V. P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9132-0 · Cited by 1,910
“(94), caprolactone (95,96), D,L-lactic acid (55,97), spermine (98), and some others.”
BackgroundStructure and design of polymeric surfactant-based drug delivery systems
Torchilin, V. P. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00299-1 · Cited by 1,822
Nano-engineering block copolymer aggregates for drug delivery
Allen, C., Maysinger, D., & Eisenberg, A. (1999) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00058-2 · Cited by 1,358
Polymeric micelles—A new generation of colloidal drug carriers
Jones, M.-C., & Leroux, J.-C. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00039-9 · Cited by 1,256
Paclitaxel and its formulations
Singla, A. K., Garg, A., & Aggarwal, D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00986-3 · Cited by 1,100
Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery
Lavasanifar, A., Samuel, J., & Kwon, G. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00015-7 · Cited by 756
Schreier, S., Malheiros, S. V. P., & de Paula, E. (2000) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0304-4157(00)00012-5 · Cited by 727
Polymeric micelles as drug delivery vehicles
Ahmad, Z., Shah, A., Siddiq, M., & Kraatz, H.-B. (2014) · RSC Adv. · doi:10.1039/c3ra47370h · Cited by 610
Targeted polymeric micelles for delivery of poorly soluble drugs
Torchilin, V. P. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4153-5 · Cited by 543
Stimuli‐Responsive Polymersomes as Nanocarriers for Drug and Gene Delivery
Onaca, O., Enea, R., Hughes, D. W., & Meier, W. (2009) · Macromolecular Bioscience · doi:10.1002/mabi.200800248 · Cited by 465
Polymeric micelles for drug delivery
Aliabadi, H. M., & Lavasanifar, A. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.1.139 · Cited by 446
Crosasso, P., Ceruti, M., Brusa, P., Arpicco, S., Dosio, F., & Cattel, L. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00166-2 · Cited by 338
Dorai, T., Cao, Y., Dorai, B., Buttyan, R., & Katz, A. E. (2001) · The Prostate · doi:10.1002/pros.1074 · Cited by 338
Greish, K., Fang, J., Inutsuka, T., Nagamitsu, A., & Maeda, H. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342130-00002 · Cited by 278
Peltier, S., Oger, J.-M., Lagarce, F., Couet, W., & Benoît, J.-P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0022-2 · Cited by 274
Burt, H. M., Zhang, X., Toleikis, P., Embree, L., & Hunter, W. L. (1999) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00067-3 · Cited by 254
Self-citationPEG- b -PLA micelles and PLGA- b -PEG- b -PLGA sol–gels for drug delivery
Cho, H., Gao, J., & Kwon, G. S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.015 · Cited by 186
“In contrast to PEG-b-PLA nanoparticles, PEG-b-PLA micelles have a lower PLA molecular weight, tend to be smaller, less stable and have more rapid release of anticancer agent in blood by disassembly and/or diffusion [36-38].”
BackgroundSurapaneni, M. S., Das, S. K., & Das, N. G. (2012) · ISRN Pharmacology · doi:10.5402/2012/623139 · Cited by 179
The in vivo fate of polymeric micelles
Cai, Y., Qi, J., Lu, Y., He, H., & Wu, W. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114463 · Cited by 154
Liu, J., Zeng, F., & Allen, C. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.12.013 · Cited by 139
Danquah, M., Fujiwara, T., & Mahato, R. I. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.081 · Cited by 101
Thermosensitive micelles from PEGylated oligopeptides
Xu, J. Z., Moon, S. H., Jeong, B., & Sohn, Y. S. (2007) · Polymer · doi:10.1016/j.polymer.2007.04.061 · Cited by 15
Metadata
- Authors
- Ramaswamy, M., Zhang, X., Burt, H. M., & Wasan, K. M.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- American Geophysical Union (AGU)
- Published
- 1997-04
- Volume
- 86
- Issue
- 4
- Pages
- 460-464
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W1967341162
- Cited by
- 98
- References
- 1
- FWCI
- 6.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.